{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:04:27Z","timestamp":1789869867477,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s11910-009-0026-5","type":"journal-article","created":{"date-parts":[[2009,3,7]],"date-time":"2009-03-07T00:25:57Z","timestamp":1236385557000},"page":"173-180","source":"Crossref","is-referenced-by-count":28,"title":["Sleep disorders and daytime sleepiness in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"9","author":[{"given":"Renee","family":"Monderer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thorpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,8]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","volume":"11","author":"A.J. Lees","year":"1988","unstructured":"Lees AJ, Blackburn NA, Campbell VL: The nighttime problems of Parkinson\u2019s disease. Clin Neuropharmacol 1988, 11:512\u2013519.","journal-title":"Clin Neuropharmacol"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.870130606","volume":"13","author":"E. Tandberg","year":"1998","unstructured":"Tandberg E, Larsen JP, Karlsen K: A community-based study of sleep disorders patients with Parkinson\u2019s disease. Mov Disord 1998, 13:895\u2013899.","journal-title":"Mov Disord"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.sleep.2005.03.011","volume":"6","author":"N.J. Diederich","year":"2005","unstructured":"Diederich NJ, Vaillant M, Mancuso G, et al.: Progressive sleep \u2018destructuring\u2019 in Parkinson\u2019s disease. A polysomnographic study in 46 patients. Sleep Med 2005, 6:313\u2013318.","journal-title":"Sleep Med"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4088\/JCP.v67n0613","volume":"67","author":"L.L. Borek","year":"2006","unstructured":"Borek LL, Kohn R, Friedman JH: Md and sleep in Parkinson\u2019s disease. J Clin Psychiatry 2006, 67:958\u2013963.","journal-title":"J Clin Psychiatry"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.10167","volume":"17","author":"S. Kumar","year":"2002","unstructured":"Kumar S, Bhatia M, Behari M: Sleep disorders in Parkinson\u2019s disease. Mov Disord 2002, 17:775\u2013781.","journal-title":"Mov Disord"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1034\/j.1600-0579.2003.00208.x","volume":"51","author":"N.S. Gneratne","year":"2003","unstructured":"Gneratne NS, Weaver TE, Carter JR, et al.: Functional outcomes of excessive daytime sleepiness in older adults. J Am Geriatr Soc 2003, 51:642\u2013649.","journal-title":"J Am Geriatr Soc"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2006.100370","volume":"78","author":"M.D. Gjerstad","year":"2007","unstructured":"Gjerstad MD, Wentzel-Larsen T, Aarsland D, Larsen JP: Insomnia in Parkinson\u2019s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007, 78:476\u2013479.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.sleep.2004.01.003","volume":"5","author":"G. Plazzi","year":"2004","unstructured":"Plazzi G: REM sleep behavior disorders in Parkinson\u2019s disease and other Parkinson\u2019s disorders. Sleep Med 2004, 5:195\u2013199.","journal-title":"Sleep Med"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2005.01.001","volume":"9","author":"I. Arnulf","year":"2005","unstructured":"Arnulf I: Excessive daytime somnolence in parkinsonism. Sleep Med Rev 2005, 9:185\u2013200.","journal-title":"Sleep Med Rev"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002826-200105000-00013","volume":"24","author":"J.L. Montastruc","year":"2001","unstructured":"Montastruc JL, Brefel-Courban C, Senard JM, et al.: Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol 2001, 24:181\u2013183.","journal-title":"Clin Neuropharmacol"},{"key":"26_CR11","first-page":"249","volume":"113","author":"T.C. Wetter","year":"2001","unstructured":"Wetter TC, Trenkwalder C, Gershanik O, Hogl B: Polysomnographic measures in Parkinson\u2019s disease: a comparison between patients with and without REM sleep disturbances. Wien Klin Wochenschr 2001, 113:249\u2013253.","journal-title":"Wien Klin Wochenschr"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.21002","volume":"21","author":"I. Shpirer","year":"2006","unstructured":"Shpirer I, Minovitz A, Klein C, et al.: Excessive daytime sleepiness in patients with Parkinson\u2019s disease: a polysomnography study. Mov Disord 2006, 21:1432\u20131438.","journal-title":"Mov Disord"},{"key":"26_CR13","first-page":"193","volume":"21","author":"A. Friedman","year":"1980","unstructured":"Friedman A: Sleep pattern in Parkinson\u2019s disease. Acta Med Pol 1980, 21:193\u2013199.","journal-title":"Acta Med Pol"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.10242","volume":"17","author":"H. Brunner","year":"2002","unstructured":"Brunner H, Wetter TC, Hogl B, et al.: Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson\u2019s disease: effects of dopaminergic treatment. Mov Disord 2002, 17:928\u2013933.","journal-title":"Mov Disord"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10072-004-0364-7","volume":"25","author":"C. Scaglione","year":"2005","unstructured":"Scaglione C, Vignatelli L, Plazzi G, et al.: REM sleep behavior disorder in Parkinson\u2019s disease: a questionnaire-based study. Neurol Sci 2005, 25:316\u2013321.","journal-title":"Neurol Sci"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-510X(01)00480-4","volume":"186","author":"I. Eisensehr","year":"2001","unstructured":"Eisensehr I, von Lindeiner H, Jager M, et al.: REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson\u2019s disease: is there a need for polysomnography? J Neurol Sci 2001, 186:7\u201311.","journal-title":"J Neurol Sci"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00207450701591065","volume":"118","author":"A. Nass","year":"2008","unstructured":"Nass A, Nass RD: Actigraphic evidence for night-time hyperkinesias in Parkinson\u2019s disease. Int J Neurosci 2008, 118:291\u2013310.","journal-title":"Int J Neurosci"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3349\/ymj.2000.41.2.167","volume":"41","author":"M.S. Lee","year":"2000","unstructured":"Lee MS, Rinne JO, Marsden CD: The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J 2000, 41:167\u2013184.","journal-title":"Yonsei Med J"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","volume":"130","author":"R. Fronczek","year":"2007","unstructured":"Fronczek R, Overeem S, Lee SY, et al.: Hypocretin (orexin) loss in Parkinson\u2019s diasease. Brain 2007, 130:1577\u20131585.","journal-title":"Brain"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"T.C. Thannickal","year":"2007","unstructured":"Thannickal TC, Lai YY, Siegel JM: Hypocretin (orexin) cell loss in Parkinson\u2019s disease. Brain 2007, 130:1586\u20131595.","journal-title":"Brain"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2006.08.004","volume":"250","author":"K. Yasui","year":"2006","unstructured":"Yasui K, Inoue Y, Kanbayashi T, et al.: CSF orexin levels in Parkinson\u2019s disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 2006, 250:120\u2013123.","journal-title":"J Neurol Sci"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(93)91457-4","volume":"608","author":"R.K. Zoltoski","year":"1993","unstructured":"Zoltoski RK, Velazquez-Moctezuma J, Shiromani PJ, et al.: The relative effects of selective M1 muscarinic antagonists on rapid eye movement sleep. Brain Res 1993, 608:186\u2013190.","journal-title":"Brain Res"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/mds.10233","volume":"17","author":"D. Garcia-Borreguero","year":"2002","unstructured":"Garcia-Borreguero D, Caminero AB, de la Llave Y, et al.: Decreased phasic EMG activity during rapid eye movement sleep in treatment of naive Parkinson\u2019s disease: effects of treatment with levodopa and progression of illness. Mov Disord 2002, 17:934\u2013941.","journal-title":"Mov Disord"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.sleep.2004.01.016","volume":"5","author":"D.B. Rye","year":"2004","unstructured":"Rye DB: Parkinson\u2019s disease and RLS: the dopaminergic bridge. Sleep Med 2004, 5:317\u2013328.","journal-title":"Sleep Med"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1212\/01.wnl.0000233980.25978.9d","volume":"6","author":"M.D. Gjerstad","year":"2006","unstructured":"Gjerstad MD, Alves G, Wentzel-Larsen T, et al.: Excessive daytime sleepiness in Parkinson\u2019s disease: is it the drugs or the disease? Neurology 2006, 6:853\u2013858.","journal-title":"Neurology"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-1331.2004.00971.x","volume":"12","author":"D. Kaynak","year":"2005","unstructured":"Kaynak D, Kiziltan G, Kaynak H, et al.: Sleep and sleepiness in patients with Parkinson\u2019s disease before and after dopaminergic treatment. Eur J Neurol 2005, 12:199\u2013207.","journal-title":"Eur J Neurol"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.61.1.97","volume":"61","author":"A. Razmy","year":"2004","unstructured":"Razmy A, Lang AE, Shapiro CM: Predictors of impaired daytime sleep and wakefulness in patients with Parkinson\u2019s disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004, 61:97\u2013102.","journal-title":"Arch Neurol"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1212\/WNL.48.1.81","volume":"48","author":"M.C. Kurth","year":"1997","unstructured":"Kurth MC, Adler CH, Hilaire MS, et al.: Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson\u2019s disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I. Neurology 1997, 48:81\u201387.","journal-title":"Neurology"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/WNL.44.11.2095","volume":"44","author":"C. Hublin","year":"1994","unstructured":"Hublin C, Partinen M, Heinonen EH, et al.: Selegiline in the treatment of narcolepsy. Neurology 1994, 44:2095\u20132101.","journal-title":"Neurology"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00435308","volume":"70","author":"C. Thorton","year":"1980","unstructured":"Thorton C, Dore CJ, Elsworth JD, et al.: The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and md in man. Psychopharmacology 1980, 70:163\u2013166.","journal-title":"Psychopharmacology"},{"issue":"Suppl1","key":"26_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2008.02055.x","volume":"15","author":"A.H. Schapira","year":"2008","unstructured":"Schapira AH: Progress in neuroprotection in Parkinson\u2019s disease. Eur J Neurol 2008, 15(Suppl 1):5\u201313.","journal-title":"Eur J Neurol"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.sleep.2003.10.010","volume":"5","author":"A. Cicolin","year":"2004","unstructured":"Cicolin A, Lopiano L, Zibetti M, et al.: Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med 2004, 5:207\u2013210.","journal-title":"Sleep Med"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3171\/jns.2006.104.4.502","volume":"104","author":"K. Lyons","year":"2006","unstructured":"Lyons K, Pahwa R: Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson\u2019s disease. J Neurosurg 2006, 104:502\u2013505.","journal-title":"J Neurosurg"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000107943","volume":"58","author":"M. Zibetti","year":"2007","unstructured":"Zibetti M, Torre E, Cinquepalmi A, et al.: Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007, 58:218\u2013223.","journal-title":"Eur Neurol"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.21541","volume":"22","author":"I. Ghorayeb","year":"2007","unstructured":"Ghorayeb I, Loundou A, Auquier P, et al.: A nationwide survey of excessive daytime sleepiness in Parkinson\u2019s disease in France. Mov Disord 2007, 22:1567\u20131572.","journal-title":"Mov Disord"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/gps.1709","volume":"22","author":"F. Boddy","year":"2007","unstructured":"Boddy F, Rowan EN, Lett D, et al.: Subjectively reported sleep quality and excessive daytime somnolence in Parkinson\u2019s disease with and without dementia, dementia with Lewy bodies and Alzheimer\u2019s disease. Int J Geriatr Psychiatry 2007, 22:529\u2013535.","journal-title":"Int J Geriatr Psychiatry"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.parkreldis.2005.05.007","volume":"11","author":"J. Wegelin","year":"2005","unstructured":"Wegelin J, McNamara P, Durso R, et al.: Correlates of excessive daytime sleepiness in Parkinson\u2019s disease. Parkinsonism Rel Disord 2005, 11:441\u2013448.","journal-title":"Parkinsonism Rel Disord"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.sleep.2005.12.002","volume":"7","author":"C. Monaca","year":"2006","unstructured":"Monaca C, Duhamel A, Jacquesson JM, Ozsancak C, et al.: Vigilance troubles in Parkinson\u2019s disease: a subjective and objective polysomnographic study. Sleep Med 2006, 7:448\u2013453.","journal-title":"Sleep Med"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/mds.20163","volume":"19","author":"Y. Korner","year":"2004","unstructured":"Korner Y, Meindorfner C, Moller JC, et al.: Predictors of sudden onset of sleep. Mov Disord 2004, 19:1298\u20131305.","journal-title":"Mov Disord"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.sleep.2003.01.001","volume":"5","author":"R. Manni","year":"2003","unstructured":"Manni R, Terzaghi M, Sartori I, et al.: Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Med 2003, 5:189\u2013193.","journal-title":"Sleep Med"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mds.20245","volume":"19","author":"I. Rissling","year":"2004","unstructured":"Rissling I, Geller F, Bandmann O, et al.: Dopamine receptor gene polymorphisms in Parkinson\u2019s disease patients reporting \u201csleep attacks.\u201d; Mov Disord 2004, 19:1279\u20131284.","journal-title":"Mov Disord"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/sleep\/28.7.871","volume":"28","author":"I. Rissling","year":"2005","unstructured":"Rissling I, K\u00f6rner K, Geller F, et al.: Preprohypocretin polymorphism in Parkinson\u2019s disease patients reporting \u201csleep attacks.\u201d Sleep 2005, 28:871\u2013875.","journal-title":"Sleep"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/mds.20412","volume":"20","author":"C. Meindorfner","year":"2005","unstructured":"Meindorfner C, Korner Y, Moller JC, et al.: Driving in Parkinson\u2019s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005, 20:832\u2013842.","journal-title":"Mov Disord"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/01.wnl.0000245086.32787.61","volume":"67","author":"E.Y. Uc","year":"2006","unstructured":"Uc EY, Rizzo M, Anderson SW, et al.: Driving with distraction in Parkinson\u2019s disease. Neurology 2006, 67:1774\u20131780.","journal-title":"Neurology"},{"key":"26_CR45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11910-003-0073-2","volume":"3","author":"C.L. Comella","year":"2003","unstructured":"Comella CL: Sleep disturbances in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 2003, 3:173\u2013180.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","volume":"25","author":"B. Hogl","year":"2002","unstructured":"Hogl B, Saletu M, Brandauer E, et al.: Modafinil for the treatment of daytime sleepiness in Parkinson\u2019s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002, 25:905\u2013909.","journal-title":"Sleep"},{"key":"26_CR47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","volume":"18","author":"C.H. Adler","year":"2003","unstructured":"Adler CH, Caviness JN, Hentz JG, et al.: Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson\u2019s disease. Mov Disord 2003, 18:287\u2013293.","journal-title":"Mov Disord"},{"key":"26_CR48","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","volume":"76","author":"W.G. Ondo","year":"2005","unstructured":"Ondo WG, Fayle R, Atassi F, et al.: Modafinil for daytime somnolence in Parkinson\u2019s disease: double blind, placebo controlled prallel trial. J Neurol Neruosurg Psychiatry 2005, 76:1636\u20131639.","journal-title":"J Neurol Neruosurg Psychiatry"},{"key":"26_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2003.08.010","volume":"217","author":"P. Brga-Neto","year":"2004","unstructured":"Brga-Neto P, da Silva-Junior FP, Sueli Monte F, et al.: Snoring and excessive daytime sleepiness in Parkinson\u2019s disease. J Neurol Sci 2004, 217:41\u201345.","journal-title":"J Neurol Sci"},{"key":"26_CR50","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","volume":"58","author":"I. Arnulf","year":"2002","unstructured":"Arnulf I, Konofal E, Merino-Andreu M, et al.: Parkinson\u2019s disease and sleepiness; an integral part of PD. Neurology 2002, 58:1019\u20131024.","journal-title":"Neurology"},{"key":"26_CR51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/mds.20624","volume":"20","author":"N.J. Diederich","year":"2005","unstructured":"Diederich NJ, Vaillant M, Leischen M, et al.: Sleep apnea syndrome in Parkinson\u2019s disease. A case control study in 49 patients. Mov Disord 2005, 20:1413\u20131418.","journal-title":"Mov Disord"},{"key":"26_CR52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.wnf.0000174932.82134.e2","volume":"28","author":"C. Juri","year":"2005","unstructured":"Juri C, Chan\u00e1 P, Tapia J, et al.: Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol 2005, 28:185\u2013187.","journal-title":"Clin Neuropharmacol"},{"key":"26_CR53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8","volume":"14","author":"D. Kunz","year":"1999","unstructured":"Kunz D, Bes F: Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999, 14:507\u2013511.","journal-title":"Mov Disord"},{"key":"26_CR54","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/mds.21624","volume":"22","author":"J.C. Gomez-Esteban","year":"2007","unstructured":"Gomez-Esteban JC, Zarranz JJ, Tijero B, et al.: Restless legs syndrome in Parkinson\u2019s disease. Mov Disord 2007, 22:1912\u20131916.","journal-title":"Mov Disord"},{"key":"26_CR55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/mds.20734","volume":"21","author":"T. Nomura","year":"2006","unstructured":"Nomura T, Inoue Y, Miyake M, et al.: Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson\u2019s disease. Mov Disord 2006, 21:380\u2013384.","journal-title":"Mov Disord"},{"key":"26_CR56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2007.09.033","volume":"266","author":"H.V. Loo","year":"2008","unstructured":"Loo HV, Tan EK: Case-control study of restless legs syndrome and quality of sleep in Parkinson\u2019s disease. J Neurol Sci 2008, 266:145\u2013149.","journal-title":"J Neurol Sci"},{"key":"26_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2006.06.023","volume":"250","author":"T. Nomura","year":"2006","unstructured":"Nomura T, Inoue Y, Nakashima K: Clinical characteristics of restless legs syndrome in patients with Parkinson\u2019s disease. J Neurol Sci 2006, 250:39\u201344.","journal-title":"J Neurol Sci"},{"key":"26_CR58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00415-003-0957-8","volume":"250","author":"S. Happe","year":"2003","unstructured":"Happe S, Pirker W, Kloch G, et al.: Periodic leg movements in patients with Parkinson\u2019s disease are associated with reduced striatal dopamine transporter binding. J Neurol 2003, 250:83\u201386.","journal-title":"J Neurol"},{"key":"26_CR59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/PL00007859","volume":"249","author":"M. Michaud","year":"2002","unstructured":"Michaud M, Soucy JP, Chabli A, et al.: SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 2002, 249:164\u2013170.","journal-title":"J Neurol"},{"key":"26_CR60","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1212\/WNL.54.2.502","volume":"54","author":"H.M. Ruottinen","year":"2000","unstructured":"Ruottinen HM, Partinen M, Hublin C, et al.: An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000, 54:502\u2013504.","journal-title":"Neurology"},{"key":"26_CR61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.sleep.2004.01.012","volume":"5","author":"R. Allen","year":"2004","unstructured":"Allen R: Dopamine and iron in the pathophysiology of restless legs syndrome. Sleep Med 2004, 5:385\u2013391.","journal-title":"Sleep Med"},{"key":"26_CR62","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","volume":"20","author":"C. Pacchetti","year":"2005","unstructured":"Pacchetti C, Manni R, Zangaglia R, et al.: Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson\u2019s disease. Mov Disord 2005, 20:1439\u20131448.","journal-title":"Mov Disord"},{"key":"26_CR63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.nrl.0000257848.06462.46","volume":"13","author":"M.G. Hickey","year":"2007","unstructured":"Hickey MG, Demaerschalk BM, Caselli RJ, et al.: \u201cIdiopathic\u201d rapid-eye-movement sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist 2007, 13:98\u2013101.","journal-title":"Neurologist"},{"key":"26_CR64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.wnl.0000168864.97813.e0","volume":"65","author":"A. Irazno","year":"2005","unstructured":"Irazno A, Santamaria J, Rye DB, et al.: Characteristics of REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005, 65:247\u2013252.","journal-title":"Neurology"},{"key":"26_CR65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/mds.21255","volume":"22","author":"L.L. Borek","year":"2007","unstructured":"Borek LL, Kohn R, Friedman JH: Phenomenology of dreams in Parkinson\u2019s disease. Mov Disord 2007, 22:198\u2013202.","journal-title":"Mov Disord"},{"key":"26_CR66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/jnnp.2007.116830","volume":"79","author":"M.D. Gjerstad","year":"2008","unstructured":"Gjerstad MD, Boeve B, Wentzel-Larsen T, et al.: Occurrence of clinical correlates of REM sleep behavior disorder in patients with Parkinson\u2019s disease over time. J Neurol Neurosurg Psychiatry 2008, 79:387\u2013391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"26_CR67","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/01.wnl.0000278114.14096.74","volume":"69","author":"M. Vendette","year":"2007","unstructured":"Vendette M, Gagnon JF, Decary A, et al.: REM sleep behavior predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007, 69:1843\u20131849.","journal-title":"Neurology"},{"key":"26_CR68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.870110216","volume":"11","author":"A. Tan","year":"1996","unstructured":"Tan A, Salgado M, Fahn S: Rapid eye movement sleep behavior disorder preceding Parkinson\u2019s disease with therapeutic response to levodopa. Mov Disord 1996, 11:214\u2013216.","journal-title":"Mov Disord"},{"key":"26_CR69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1389-9457(03)00072-8","volume":"4","author":"B.F. Boeve","year":"2003","unstructured":"Boeve BF, Silber MH, Ferman TJ: Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003, 4:281\u2013284.","journal-title":"Sleep Med"},{"key":"26_CR70","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00002826-200207000-00002","volume":"25","author":"B. Bruguerolle","year":"2002","unstructured":"Bruguerolle B, Simon N: Biologic rhythms and Parkinson\u2019s disease: a chronopharmacological approach to considering fluctuations in function. Clin Neuropharmacol 2002, 25:194\u2013201.","journal-title":"Clin Neuropharmacol"},{"key":"26_CR71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07420520701420717","volume":"24","author":"G.L. Willis","year":"2007","unstructured":"Willis GL, Turner EJ: Primary and secondary features of Parkinson\u2019s disease improve with strategic exposure to bright light: a case series study. Chronobiol Int 2007, 24:521\u2013537.","journal-title":"Chronobiol Int"},{"key":"26_CR72","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.21542","volume":"22","author":"S. Paus","year":"2007","unstructured":"Paus S, Schmitz-Hubsch T, Wullner U, et al.: Bright light therapy in Parkinson\u2019s disease: a pilot study. Mov Disord 2007, 22:1495\u20131498.","journal-title":"Mov Disord"},{"key":"26_CR73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","volume":"6","author":"G.A. Dowling","year":"2005","unstructured":"Dowling GA, Mastick J, Colling E, et al.: Melatonin for sleep disturbances in Parkinson\u2019s disease. Sleep Med 2005, 6:459\u2013466.","journal-title":"Sleep Med"},{"key":"26_CR74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","volume":"254","author":"C.A. Medeiros","year":"2007","unstructured":"Medeiros CA, Carvalhedo de Bruin PR, Lopes LA, et al.: Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson\u2019s disease: a randomized, double blind, placebo-controlled study. J Neurol 2007, 254:459\u2013464.","journal-title":"J Neurol"},{"key":"26_CR75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-9081-2-15","volume":"2","author":"V. Srinivasan","year":"2006","unstructured":"Srinivasan V, Pandi-Perumal S, Cardinali D, et al.: Melatonin in Alzheimer\u2019s disease and other neurodegenerative disorders. Behav Brain Funct 2006, 2:15.","journal-title":"Behav Brain Funct"},{"key":"26_CR76","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/1531-8257(200009)15:5<986::AID-MDS1034>3.0.CO;2-I","volume":"15","author":"S. Tesei","year":"2000","unstructured":"Tesei S, Antonini A, Canesi M, et al.: Tolerability of paroxetine in Parkinson\u2019s disease: a prospective study. Mov Disord 2000, 15:986\u2013989.","journal-title":"Mov Disord"},{"key":"26_CR77","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199903113401011","volume":"240","author":"J.L. Cummings","year":"1999","unstructured":"Cummings JL: Managing psychosis in patients with Parkinson\u2019s disease: a review. N Engl J Med 1999, 240:801\u2013803.","journal-title":"N Engl J Med"},{"key":"26_CR78","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.10374","volume":"18","author":"H.H. Fernandez","year":"2003","unstructured":"Fernandez HH, Trieschmann ME, Burke MA, et al.: Long-term outcome of quetiapine use for psychosis among parkinsonian patients. Mov Disord 2003, 18:510\u2013514.","journal-title":"Mov Disord"},{"key":"26_CR79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","volume":"8","author":"L.M. Shulman","year":"2002","unstructured":"Shulman LM, Taback RL, Rabinstein AA, Weiner WJ: Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease. Parkinsonian Relat Disord 2002, 8:193\u2013197.","journal-title":"Parkinsonian Relat Disord"},{"key":"26_CR80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mds.10134","volume":"17","author":"L.M. Shulman","year":"2002","unstructured":"Shulman LM, Wen X, Weiner WJ, et al.: Acupuncture therapy for the symptoms of Parkinson\u2019s disease. Mov Disord 2002, 17:799\u2013802.","journal-title":"Mov Disord"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-009-0026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-009-0026-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-009-0026-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:28:16Z","timestamp":1559420896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-009-0026-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11910-009-0026-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}